Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-α, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy

Human Immunology

Volumn 61, Issue 12, 2000, Pages 1262-1269

  Nishimura, Masataka ^a   Maeda, Michiyuki ^b   Matsuoka, Masao ^c   Mine, Hideko ^d   Saji, Hiroh ^d   Matsui, Makoto ^a   Kuroda, Yasuo ^e   Kawakami, Hideshi ^f   Uchiyama, Takashi ^g  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Kyoto University   (Japan)

^d JAPANESE RED CROSS SOCIETY   (Japan)

^e SAGA UNIVERSITY   (Japan)

^f HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

HLA; HTLV I associated myelopathy (HAM); Human T cell lymphotropic virus type I (HTLV I); TNF receptor; Tumor necrosis factor (TNF)

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; LYMPHOTOXIN; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ALLELE; ARTICLE; CHROMOSOME 1P; CHROMOSOME 6; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXON; GENE FREQUENCY; GENE LOCATION; GENETIC POLYMORPHISM; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; SPINAL CORD DISEASE; T CELL LYMPHOMA;

ALLELES; ANTIGENS, CD; CARRIER STATE; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LINKAGE DISEQUILIBRIUM; LYMPHOTOXIN-ALPHA; MICROSATELLITE REPEATS; PARAPARESIS, TROPICAL SPASTIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034488237     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00182-8     Document Type: Article

References (35)

1. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I
2. Immunogenetics of HTLV-I/II and associated diseases
3. Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia/lymphoma in a black population
4. Evolving view of the major histocompatibility complex
5. A map of the human major histocompatibility complex
6. Genetic structure of IDDM1. Two separate regions in the major histocompatibility complex contribute to susceptibility or protection
7. Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus
8. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene
9. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: Relevance to genetic predisposition to systemic lupus erythematosus
10. Genetic contribution of the tumor necrosis factor region in Guillain-Barré syndrome
11. Human T lymphocyte virus type I-induced myeloneuropathy in rats: Implication of local activation of the pX and tumor necrosis factor-alpha genes in pathogenesis
12. TNF-β produced by human T lymphotropic virus type I-infected cells influences the proliferation of human endothelial cells and fibroblasts
13. Polymorphisms of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese
14. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter
15. A common functional polymorphism (C-A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α
16. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus
17. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP
18. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers
19. Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: No association with narcolepsy
20. Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production
21. Identification of a rare BglII polymorphism in the promoter region of the human TNF receptor type I (p55) gene
22. HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis
23. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes
24. TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes
25. Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion
26. Polymorphism of the 5′-flanking region of the tumor necrosis factor (TNF)-α gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis
27. Secretion of tumor necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease
28. Constitutive production of interleukin-6 and tumor necrosis factor-α from spontaneously proliferating T cells in patients with human T cell lymphotropic virus type-I/II
29. Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy
30. Increased replication of HTLV-I in HTLV-I-associated myelopathy
31. Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor
32. A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R
33. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation
34. Tumor necrosis factor-α in murine autoimmune lupus nephritis
35. Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy